NO964032L - Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand - Google Patents

Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Info

Publication number
NO964032L
NO964032L NO964032A NO964032A NO964032L NO 964032 L NO964032 L NO 964032L NO 964032 A NO964032 A NO 964032A NO 964032 A NO964032 A NO 964032A NO 964032 L NO964032 L NO 964032L
Authority
NO
Norway
Prior art keywords
ligand
murine
kit
protein
fusion
Prior art date
Application number
NO964032A
Other languages
English (en)
Norwegian (no)
Other versions
NO964032D0 (no
Inventor
Karl H Nocka
Robert B Lobell
Original Assignee
Cytomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomed Inc filed Critical Cytomed Inc
Publication of NO964032D0 publication Critical patent/NO964032D0/no
Publication of NO964032L publication Critical patent/NO964032L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO964032A 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand NO964032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/220,379 US5525708A (en) 1994-03-28 1994-03-28 Covalent dimer of kit ligand
PCT/US1995/003866 WO1995026199A1 (en) 1994-03-28 1995-03-28 Covalent dimers of kit ligand and flt-3/flk-2 ligand

Publications (2)

Publication Number Publication Date
NO964032D0 NO964032D0 (no) 1996-09-25
NO964032L true NO964032L (no) 1996-11-28

Family

ID=22823324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964032A NO964032L (no) 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Country Status (10)

Country Link
US (1) US5525708A (ja)
EP (1) EP0759767A1 (ja)
JP (1) JPH09512706A (ja)
AU (1) AU2199895A (ja)
CA (1) CA2186496A1 (ja)
FI (1) FI963900L (ja)
HU (1) HU9602682D0 (ja)
MX (1) MX9604394A (ja)
NO (1) NO964032L (ja)
WO (1) WO1995026199A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
CZ307995A3 (en) 1993-05-24 1996-10-16 Immunex Corp Ligands for flt3 receptors
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor
US7361330B2 (en) * 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
EP0961824A4 (en) * 1996-07-10 2003-01-29 Immunex Corp METHOD FOR ACTIVATING DENTRITIC CELLS
AU751498B2 (en) * 1997-04-11 2002-08-15 G.D. Searle & Co. flt3 ligand chimeric proteins
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
US20030077263A1 (en) * 1999-10-29 2003-04-24 Immunex Corporation Method of activating dendritic cells
AU2005306894B2 (en) 2004-11-05 2011-11-24 Northwestern University Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders
US8093046B2 (en) * 2006-05-31 2012-01-10 Philadelphia Health and Education Corporation d/b/c Drexel University College of Medicine CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions
KR20120097481A (ko) * 2009-07-20 2012-09-04 내셔날 쳉쿵 유니버시티 사람 혈청 알부민(ＨＳＡ)의 변이체와 컨쥬게이션된 αｖβ3 인테그린에 대해 선택적인 폴리펩타이드 및 이의 약제학적 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
JP2657113B2 (ja) * 1989-10-16 1997-09-24 アムジエン・インコーポレーテツド 幹細胞因子
DK0423980T3 (da) * 1989-10-16 2000-10-09 Amgen Inc Stamcellefaktor
WO1992000376A1 (en) * 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
WO1993005795A1 (en) * 1991-09-13 1993-04-01 Boron Biologicals, Inc. Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
DK0639979T3 (da) * 1992-04-23 2002-12-02 Sloan Kettering Inst Cancer Ligand for c-kit-receptoren og fremgangsmåde til anvendelse heraf
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors

Also Published As

Publication number Publication date
FI963900A7 (fi) 1996-11-27
EP0759767A1 (en) 1997-03-05
JPH09512706A (ja) 1997-12-22
CA2186496A1 (en) 1995-10-05
FI963900A0 (fi) 1996-09-27
AU2199895A (en) 1995-10-17
FI963900L (fi) 1996-11-27
NO964032D0 (no) 1996-09-25
WO1995026199A1 (en) 1995-10-05
MX9604394A (es) 1997-07-31
US5525708A (en) 1996-06-11
HU9602682D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
NO964032L (no) Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand
Keski-Oja et al. Dimeric character of fibronectin, a major cell surface-associated glycoprotein
ATE252113T1 (de) Verwendung von wnt polypeptiden
Urdal et al. Affinity purification and chemical analysis of the interleukin-1 receptor.
DK25489A (da) Fremgangsmaade til fremstilling af en secerneret human-pdgf-receptoranalog, en secerneret biologisk aktiv peptiddimer henholdsvis en secerneret ligandbindende receptoranalog samt farmaceutisk sammensaetning omfattende samme
TW221675B (ja)
ATE369383T1 (de) Monoklonale antikörper spezifisch für den zytotoxischen lymphozyten-reifefaktor
DE59109269D1 (de) Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung
ES526541A0 (es) Un procedimiento para preparar una muteina sintetica de una proteina biologicamente activa
CY1108500T1 (el) Πολυπεπτιδια ομολογα με vefg και bmp1
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
ATE112573T1 (de) Inhibin und dessen reinigung.
ATE125869T1 (de) Wachstumshormonfusionsproteine.
DE69132275D1 (de) Beta-type ähnlicher transformierender wachstumfaktor
SI1511770T1 (sl) Glikoprotein VI-Fc fuzijski protein za zdravljenje vaskularnih bolezni
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
KR920703134A (ko) 생유기체의 생물부, 특히 기관을 생성하기 위한 활성물질 복합체, 이를 제조하는 방법 및 이의 용도
DE68928710D1 (de) T-Zellen-Wachstumsfaktor
MX9203879A (es) Muteina de il-6 con cisteina parcialmente suprimida.
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
DE69825976D1 (de) Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen
ATE421886T1 (de) Produktion von blutzellen mittels aktivierung von cd163
Levesque et al. Evidence for two functionally different fibrinogen receptors on hemopoietic cells: The glycoprotein IIb–IIIa and the mitogenic fibrinogen receptor
Poggi et al. Partial purification and characterization of porcine platelet-derived growth factor (PDGF)